Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanowires | 4 | 2016 | 31 | 0.770 |
Why?
|
| Esophageal Achalasia | 1 | 2022 | 94 | 0.740 |
Why?
|
| Esophagoscopy | 1 | 2022 | 390 | 0.690 |
Why?
|
| Arginase | 1 | 2019 | 80 | 0.640 |
Why?
|
| Treatment Refusal | 1 | 2022 | 430 | 0.630 |
Why?
|
| Laboratories | 1 | 2018 | 462 | 0.480 |
Why?
|
| Prejudice | 1 | 2018 | 563 | 0.470 |
Why?
|
| Research Personnel | 1 | 2018 | 582 | 0.450 |
Why?
|
| Minority Groups | 1 | 2018 | 1201 | 0.380 |
Why?
|
| Cell Membrane | 3 | 2015 | 3682 | 0.370 |
Why?
|
| Gene Frequency | 1 | 2017 | 3613 | 0.360 |
Why?
|
| Thymidine Kinase | 2 | 2021 | 286 | 0.360 |
Why?
|
| Physician-Patient Relations | 1 | 2022 | 3242 | 0.310 |
Why?
|
| Lymphoma, B-Cell | 1 | 2013 | 935 | 0.280 |
Why?
|
| CHO Cells | 4 | 2016 | 1389 | 0.250 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 3202 | 0.240 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2418 | 0.230 |
Why?
|
| Macrophages | 1 | 2019 | 5745 | 0.230 |
Why?
|
| Immunotherapy, Adoptive | 3 | 2021 | 1455 | 0.210 |
Why?
|
| Cross-Priming | 1 | 2021 | 75 | 0.190 |
Why?
|
| Cricetulus | 4 | 2016 | 815 | 0.190 |
Why?
|
| Natural Cytotoxicity Triggering Receptor 3 | 1 | 2020 | 14 | 0.180 |
Why?
|
| Mental Competency | 1 | 2022 | 175 | 0.180 |
Why?
|
| Genes, Reporter | 2 | 2021 | 1529 | 0.170 |
Why?
|
| Competitive Behavior | 1 | 2018 | 77 | 0.150 |
Why?
|
| Natural Killer T-Cells | 1 | 2021 | 311 | 0.150 |
Why?
|
| Luciferases | 1 | 2019 | 716 | 0.140 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5640 | 0.140 |
Why?
|
| Limit of Detection | 1 | 2017 | 280 | 0.140 |
Why?
|
| Neoplasms | 3 | 2021 | 22075 | 0.140 |
Why?
|
| Osteosarcoma | 1 | 2020 | 897 | 0.120 |
Why?
|
| Cobalt | 1 | 2014 | 155 | 0.120 |
Why?
|
| Equipment Design | 2 | 2020 | 3520 | 0.120 |
Why?
|
| Focal Adhesions | 1 | 2014 | 114 | 0.110 |
Why?
|
| Nanotubes | 1 | 2014 | 77 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2017 | 1493 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1784 | 0.100 |
Why?
|
| Point Mutation | 1 | 2017 | 1594 | 0.100 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2016 | 432 | 0.100 |
Why?
|
| Nanostructures | 1 | 2016 | 547 | 0.090 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2203 | 0.090 |
Why?
|
| Cytosol | 1 | 2014 | 887 | 0.090 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 938 | 0.090 |
Why?
|
| Animals | 11 | 2021 | 167960 | 0.080 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 806 | 0.080 |
Why?
|
| Adenine | 1 | 2013 | 975 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 4550 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2021 | 6465 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2019 | 8512 | 0.060 |
Why?
|
| Glioblastoma | 1 | 2020 | 3482 | 0.060 |
Why?
|
| Piperidines | 1 | 2013 | 1650 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2021 | 3105 | 0.060 |
Why?
|
| Pyrazoles | 1 | 2013 | 1999 | 0.050 |
Why?
|
| Calcium | 1 | 2016 | 5725 | 0.050 |
Why?
|
| Mice | 5 | 2021 | 81209 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2020 | 3583 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 2803 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 3016 | 0.050 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2020 | 34 | 0.050 |
Why?
|
| Ganciclovir | 1 | 2020 | 252 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 18137 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2014 | 18955 | 0.040 |
Why?
|
| Urine | 1 | 2020 | 363 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5251 | 0.040 |
Why?
|
| Humans | 9 | 2022 | 760613 | 0.040 |
Why?
|
| Egtazic Acid | 1 | 2016 | 169 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2020 | 2262 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2020 | 753 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 941 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 16932 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 1455 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2020 | 1403 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2020 | 1802 | 0.030 |
Why?
|
| Transfection | 1 | 2021 | 5781 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2020 | 1489 | 0.030 |
Why?
|
| Cell Count | 1 | 2016 | 1835 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 13262 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2016 | 732 | 0.020 |
Why?
|
| Microfluidics | 1 | 2016 | 652 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2016 | 709 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2020 | 2536 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2020 | 2829 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4571 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2015 | 3094 | 0.020 |
Why?
|
| Male | 3 | 2022 | 359718 | 0.020 |
Why?
|
| Cell Movement | 1 | 2020 | 5206 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 1972 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2020 | 3061 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3844 | 0.020 |
Why?
|
| Kinetics | 1 | 2014 | 6377 | 0.020 |
Why?
|
| Software | 1 | 2020 | 4419 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2380 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 10181 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9406 | 0.010 |
Why?
|
| Female | 3 | 2020 | 391246 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 220007 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 29957 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 169143 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 220359 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(4)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_